Advertisement

Topics

Novartis Joins Innovative Solution Trend for Clinical Trials: Launches FocalView App

20:00 EDT 24 Apr 2018 | BioSpace

The biopharma industry is starting to leverage mobile apps and other digital technologies to improve access to clinical trials. Novartis launched FocalView, an app for ophthalmic patients involved in eye-related clinical trials.

Original Article: Novartis Joins Innovative Solution Trend for Clinical Trials: Launches FocalView App

NEXT ARTICLE

More From BioPortfolio on "Novartis Joins Innovative Solution Trend for Clinical Trials: Launches FocalView App"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...